Of 3379 eligible patients, 3283 were enrolled, and no
patient withdrew consent (fi gure 1). In total, we studied
5907 intravenous catheters and 17 412 catheter days
(clinically indicated 8693 days; routine replacement
8719 days). Tables 1 and 2 show patient and catheter
characteristics. Protocol adherence was 85% in the